{"article_title": "Despite excise tax, Medtech jobs steady and even rising", "article_keywords": ["sector", "medtech", "jobs", "excise", "tax", "medical", "device", "steady", "companies", "report", "growth", "rising", "despite", "employee", "industry"], "article_url": "http://medcitynews.com/2014/08/despite-excise-tax-medtech-jobs-steady-even-rising-still-gonna-bumpy-ride/", "article_text": "Looks like employment\u2019s steady globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs.\n\nMost medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage. Of the top 15 device makers, only three experienced reductions in headcount \u2013 and two of those were simply because the companies spun off their pharmaceutical divisions. The remaining 12 increased their employee bases by 6 percent.\n\n\u201cWith more hiring than firing occurring and continued growth expected this year, the medtech industry may finally be picking up steam,\u201d the report said.\n\nA Forbes op-ed cites the report as rationale for why those clamoring for a repeal of the tax need a new argument, since stifling job growth certainly isn\u2019t one of them. The medical device excise tax, enacted as a revenue-generating portion of the Affordable Care Act, skims 2.3 percent from revenues in the sector.\n\nAdvertisement\n\n\u201cThis is not what (we) were led to expect before the excise tax started to bite,\u201d John R. Graham, former vice president for payment and health care delivery research and policy at Advamed, wrote in the article. He continues:\n\nWhat can be done to move the repeal along? Clearly, new research is needed to qualify the employment situation in the industry. Also, the industry has recoiled from suggesting a \u201cpay for\u201d to replace the revenue lost to the government if the tax is repealed. Finding a \u201cpay for\u201d is an important step for legislative success.\n\nThe main reason for large company growth was due to enhanced M&A activity, the report said, which could mean that it\u2019s still unclear whether the medical device sector has been impacted more among smaller companies. An employee count of the top medical device firms can be seen below:\n\nHere\u2019 s a chart of the top 10 firers of 2013:\n\nThe report said that employment growth doesn\u2019t necessarily mean a company is healthy \u2013 and these large companies have had a rather turbulent year. Medical device sales are falling as hospitals make cuts and shore up their budgets to save costs; reimbursement, as well, is under pressure. The report closes out with this:", "article_metadata": {"description": "Looks like employment\u2019s steady\u00a0globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs. Most\u00a0medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage. Of the top 15 device makers, only three experienced reductions in headcount \u2013 and two of those were simply because the companies spun off their pharmaceutical divisions. The remaining 12 increased their employee bases by 6 percent. \u201cWith more hiring than firing occurring and continued growth expected this year, the medtech industry may finally be picking up steam,\u201d the report\u00a0said. A Forbes op-ed cites the report as rationale for why those clamoring for a repeal of the tax need a new argument, since stifling job growth certainly isn\u2019t one of them. The medical device excise tax, enacted as a revenue-generating portion of the Affordable Care Act, skims 2.3 percent from revenues in the sector. \u201cThis is not what (we) were led to expect before the excise tax started to bite,\u201d John R. Graham, former vice president for payment and health care delivery research and policy at Advamed, wrote in the article. He continues: What can be done to move the repeal along? Clearly, new research is needed to qualify the employment situation in the industry. Also, the industry has recoiled from suggesting a \u201cpay for\u201d to replace the revenue lost to the government if the tax is repealed. Finding a \u201cpay for\u201d is an important step for legislative success. The\u00a0main reason for large company growth was due to enhanced M&A activity, the report said, which could mean\u00a0that it\u2019s still unclear whether the medical device sector has been impacted more among smaller companies. An employee count of the top medical device firms can be seen below: Here\u2019 s a chart of the top 10\u00a0firers of 2013: The report said that employment growth doesn\u2019t necessarily mean a company is healthy \u2013 and these large companies have had a rather turbulent year. Medical device sales are falling as hospitals make cuts and shore up their budgets to save costs; reimbursement, as well, is under pressure. The report closes out with this: \u2026the story in medtech employment over the course of 2013 is one of slow and steady growth, enlivened by a handful of dramatic mergers and divestments. But this story is going to change in the coming years as even bigger mergers and spinouts produce greater peaks and troughs. Fasten your seatbelts, it\u2019s going to be a bumpy ride.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Looks like employment\u2019s steady\u00a0globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs. Most\u00a0medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage. Of the top 15 device makers, only three experienced reductions in headcount \u2013 and two of those were simply because the companies spun off their pharmaceutical divisions. The remaining 12 increased their employee bases by 6 percent. \u201cWith more hiring than firing occurring and continued growth expected this year, the medtech industry may finally be picking up steam,\u201d the report\u00a0said. A Forbes op-ed cites the report as rationale for why those clamoring for a repeal of the tax need a new argument, since stifling job growth certainly isn\u2019t one of them. The medical device excise tax, enacted as a revenue-generating portion of the Affordable Care Act, skims 2.3 percent from revenues in the sector. \u201cThis is not what (we) were led to expect before the excise tax started to bite,\u201d John R. Graham, former vice president for payment and health care delivery research and policy at Advamed, wrote in the article. He continues: What can be done to move the repeal along? Clearly, new research is needed to qualify the employment situation in the industry. Also, the industry has recoiled from suggesting a \u201cpay for\u201d to replace the revenue lost to the government if the tax is repealed. Finding a \u201cpay for\u201d is an important step for legislative success. The\u00a0main reason for large company growth was due to enhanced M&A activity, the report said, which could mean\u00a0that it\u2019s still unclear whether the medical device sector has been impacted more among smaller companies. An employee count of the top medical device firms can be seen below: Here\u2019 s a chart of the top 10\u00a0firers of 2013: The report said that employment growth doesn\u2019t necessarily mean a company is healthy \u2013 and these large companies have had a rather turbulent year. Medical device sales are falling as hospitals make cuts and shore up their budgets to save costs; reimbursement, as well, is under pressure. The report closes out with this: \u2026the story in medtech employment over the course of 2013 is one of slow and steady growth, enlivened by a handful of dramatic mergers and divestments. But this story is going to change in the coming years as even bigger mergers and spinouts produce greater peaks and troughs. Fasten your seatbelts, it\u2019s going to be a bumpy ride.", "title": "Despite excise tax, Medtech jobs steady and even rising \u2013 but it\u2019s still gonna be a bumpy ride", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/Marrowmax.jpg", "updated_time": "2014-08-11T06:46:14-04:00", "url": "http://medcitynews.com/2014/08/despite-excise-tax-medtech-jobs-steady-even-rising-still-gonna-bumpy-ride/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/Marrowmax.jpg", "title": "Despite excise tax, Medtech jobs steady and even rising - but it's still gonna be a bumpy ride - MedCity News", "description": "Looks like employment\u2019s steady\u00a0globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs. Most\u00a0medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage. Of the top 15 device makers, only three experienced reductions in headcount \u2013 and two of those were simply because the companies spun off their pharmaceutical divisions. The remaining 12 increased their employee bases by 6 percent. \u201cWith more hiring than firing occurring and continued growth expected this year, the medtech industry may finally be picking up steam,\u201d the report\u00a0said. A Forbes op-ed cites the report as rationale for why those clamoring for a repeal of the tax need a new argument, since stifling job growth certainly isn\u2019t one of them. The medical device excise tax, enacted as a revenue-generating portion of the Affordable Care Act, skims 2.3 percent from revenues in the sector. \u201cThis is not what (we) were led to expect before the excise tax started to bite,\u201d John R. Graham, former vice president for payment and health care delivery research and policy at Advamed, wrote in the article. He continues: What can be done to move the repeal along? Clearly, new research is needed to qualify the employment situation in the industry. Also, the industry has recoiled from suggesting a \u201cpay for\u201d to replace the revenue lost to the government if the tax is repealed. Finding a \u201cpay for\u201d is an important step for legislative success. The\u00a0main reason for large company growth was due to enhanced M&A activity, the report said, which could mean\u00a0that it\u2019s still unclear whether the medical device sector has been impacted more among smaller companies. An employee count of the top medical device firms can be seen below: Here\u2019 s a chart of the top 10\u00a0firers of 2013: The report said that employment growth doesn\u2019t necessarily mean a company is healthy \u2013 and these large companies have had a rather turbulent year. Medical device sales are falling as hospitals make cuts and shore up their budgets to save costs; reimbursement, as well, is under pressure. The report closes out with this: \u2026the story in medtech employment over the course of 2013 is one of slow and steady growth, enlivened by a handful of dramatic mergers and divestments. But this story is going to change in the coming years as even bigger mergers and spinouts produce greater peaks and troughs. Fasten your seatbelts, it\u2019s going to be a bumpy ride.", "card": "summary", "creator": "@meghanakeshavan"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "article": {"section": "Daily", "tag": "medtech", "published_time": "2014-08-08T12:38:39-04:00", "modified_time": "2014-08-11T06:46:14-04:00"}, "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,ep vantage, jobs, medical device, medical device excise tax, medtech, , MedCity News", "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "_id": "\"57477af36914bd0286fcd897\"", "article_summary": "Looks like employment\u2019s steady globally in the medical device sector, despite the doom-and-gloom provocations from those stateside who have been concerned about the U.S. medical device excise tax killing medtech jobs.\nThe medical device excise tax, enacted as a revenue-generating portion of the Affordable Care Act, skims 2.3 percent from revenues in the sector.\nMedical device sales are falling as hospitals make cuts and shore up their budgets to save costs; reimbursement, as well, is under pressure.\nAdvertisement\u201cThis is not what (we) were led to expect before the excise tax started to bite,\u201d John R. Graham, former vice president for payment and health care delivery research and policy at Advamed, wrote in the article.\nMost medical manufacturers actually increased their employee count for the year, according to a new report from EP Vantage."}